European Patent Granted for Bone Marrow Edema Lesions

Paradigm Biopharmaceuticals Ltd is pleased to announce it has been granted a European Patent for the treatment of Bone Marrow Edema Lesions with Pentosan Polysulphate Sodium. The Patent no.2670412 entitled ‘Treatment of bone marrow edema lesions with polysaccharides’ was granted on the 3rd January 2018.

Link to story –

https://www.asx.com.au/asxpdf/20180116/pdf/43qv2v19ssr1s7.pdf